Callahan Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $5.08M | Buy |
62,666
+9,450
| +18% | +$909K | 0.39% | 59 |
|
|
2026
Q2 | $5.08M | Sell |
53,216
-3,576
| -6% | -$343K | 0.38% | 60 |
|
|
2026
Q1 | $5.89M | Buy |
56,792
+25,228
| +80% | +$2.86M | 0.49% | 52 |
|
|
2025
Q4 | $3.18M | Buy |
+31,564
| New | +$3.43M | 0.26% | 72 |
|
|
2022
Q1 | – | Sell |
-1,256
| Closed | -$219K | – | 147 |
|
|
2021
Q4 | $219K | Buy |
1,256
+1
| +0.1% | +$167 | 0.02% | 145 |
|
|
2021
Q3 | $208K | Buy |
1,255
+32
| +3% | +$5.51K | 0.03% | 141 |
|
|
2021
Q2 | $220K | Buy |
1,223
+101
| +9% | +$18.4K | 0.03% | 142 |
|
|
2021
Q1 | $216K | Sell |
1,122
-50
| -4% | -$9.6K | 0.03% | 136 |
|
|
2020
Q4 | $237K | Sell |
1,172
-108
| -8% | -$22.3K | 0.03% | 132 |
|
|
2020
Q3 | $269K | Buy |
1,280
+1
| +0.1% | +$223 | 0.04% | 123 |
|
|
2020
Q2 | $281K | Sell |
1,279
-7,150
| -85% | -$1.43M | 0.05% | 111 |
|
|
2020
Q1 | $1.46M | Buy |
8,429
+22
| +0.3% | +$3.64K | 0.31% | 68 |
|
|
2019
Q4 | $1.29M | Buy |
8,407
+3
| +0% | +$448 | 0.21% | 78 |
|
|
2019
Q3 | $1.28M | Buy |
8,404
+3
| +0% | +$474 | 0.22% | 76 |
|
|
2019
Q2 | $1.29M | Buy |
8,401
+2
| +0% | +$306 | 0.23% | 76 |
|
|
2019
Q1 | $1.35M | Buy |
8,399
+399
| +5% | +$61.9K | 0.25% | 74 |
|
|
2018
Q4 | $1.23M | Hold |
8,000
| – | – | 0.26% | 74 |
|
|
2018
Q3 | $1.2M | Sell |
8,000
-100
| -1% | -$14.2K | 0.22% | 81 |
|
|
2018
Q2 | $1.1M | Hold |
8,100
| – | – | 0.22% | 79 |
|
|
2018
Q1 | $1.08M | Hold |
8,100
| – | – | 0.22% | 80 |
|
|
2017
Q4 | $1.2M | Hold |
8,100
| – | – | 0.24% | 76 |
|
|
2017
Q3 | $1.07M | Hold |
8,100
| – | – | 0.22% | 79 |
|
|
2017
Q2 | $1.08M | Hold |
8,100
| – | – | 0.23% | 77 |
|
|
2017
Q1 | $1.09M | Hold |
8,100
| – | – | 0.25% | 74 |
|
|
2016
Q4 | $972K | Sell |
8,100
-200
| -2% | -$23.6K | 0.23% | 77 |
|
|
2016
Q3 | $1.04M | Hold |
8,300
| – | – | 0.26% | 71 |
|
|
2016
Q2 | $1.15M | Hold |
8,300
| – | – | 0.3% | 65 |
|
|
2016
Q1 | $1.05M | Hold |
8,300
| – | – | 0.29% | 64 |
|
|
2015
Q4 | $1.05M | Hold |
8,300
| – | – | 0.3% | 67 |
|
|
2015
Q3 | $959K | Hold |
8,300
| – | – | 0.29% | 69 |
|
|
2015
Q2 | $863K | Hold |
8,300
| – | – | 0.25% | 80 |
|
|
2015
Q1 | $916K | Hold |
8,300
| – | – | 0.27% | 77 |
|
|
2014
Q4 | $865K | Hold |
8,300
| – | – | 0.25% | 79 |
|
|
2014
Q3 | $797K | Hold |
8,300
| – | – | 0.25% | 82 |
|
|
2014
Q2 | $759K | Hold |
8,300
| – | – | 0.24% | 84 |
|
|
2014
Q1 | $730K | Hold |
8,300
| – | – | 0.25% | 82 |
|
|
2013
Q4 | $770K | Buy |
8,300
+1,000
| +14% | +$90.1K | 0.27% | 80 |
|
|
2013
Q3 | $597K | Hold |
7,300
| – | – | 0.23% | 82 |
|
|
2013
Q2 | $607K | Buy |
+7,300
| New | +$628K | 0.25% | 80 |
|
Other funds holding CLX
Callahan Advisors's CLX Position: Q3 2026 in Review
Callahan Advisors increased its Clorox (CLX) stake by 18% in Q3 2026, buying an estimated $909K and bringing the position to 62,666 shares worth $5.08M. The position accounts for 0.39% of the portfolio, ranked #59.
Callahan Advisors first reported a position in CLX in Q2 2013 and has held it in 39 quarters since. The position peaked at $5.89M in Q1 2026. 634 funds tracked by Wall St. Rank hold CLX as of Q3 2026.
- Callahan Advisors held 62,666 shares of Clorox worth $5.08M as of Q3 2026.
- Callahan Advisors bought 9,450 Clorox shares in Q3 2026, an estimated $909K.
- Clorox made up 0.39% of Callahan Advisors's portfolio in Q3 2026, its #59 holding.
- Callahan Advisors first reported a position in Clorox in Q2 2013 and has held it in 39 quarters since.
- Callahan Advisors's Clorox position peaked at $5.89M in Q1 2026.
- 634 funds tracked by Wall St. Rank held Clorox as of Q3 2026.
Based on Callahan Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.